Azenta reports FY2026 revenue of $622M and goodwill-driven loss; guides higher for FY2027
The life-sciences tools supplier posted 5% revenue growth and a $158M net loss after a $149M impairment, and forecast FY2027 revenue of $648-660M.
Azenta (Nasdaq: AZTA) published its fourth-quarter and full-year results on 10 November 2026 for the fiscal year ended 30 September 2026. Revenue from continuing operations rose 5% to $622 million, of which 2% was organic growth.
The company recorded a net loss of $158 million for the year. This followed a $149 million non-cash goodwill impairment, which accounts for most of the loss.
For FY2027, Azenta guided revenue to between $648 million and $660 million, with organic growth of 3-5%. It also expects adjusted EBITDA margin to expand by roughly 200-250 basis points.
The quarter also cited quality remediation and rework in its Automated Stores business. The summary available does not give further detail on the scale, cause or timing of that work, so its financial impact is not clear from the material on file.
What it means for your team
- Quality remediation and rework in Automated Stores is a point for quality teams to watch if they rely on Azenta's sample-storage systems; the available material gives no operational detail, so ask the supplier directly.
- Procurement and supplier-management teams may want to note the goodwill impairment and the guidance when reviewing supplier risk, though the impairment is non-cash.
- The FY2027 outlook of 3-5% organic growth suggests modest expected demand growth for the company's offerings.
Company's press release (SEC filing): Azenta, Inc. ↗
Article written by VigiEye from the official source (Azenta, Inc.). Claims are the company's own. AI-assisted; check the source before acting.